thiazolyl blue has been researched along with bupivacaine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellas, E; Hoare, T; Kohane, DS; Zurakowski, D | 1 |
Cheng, Y; Ding, Z; Li, C; Liu, L; Wang, X; Zhang, W; Zhang, X | 1 |
2 other study(ies) available for thiazolyl blue and bupivacaine
Article | Year |
---|---|
Rheological blends for drug delivery. II. Prolongation of nerve blockade, biocompatibility, and in vitro-in vivo correlations.
Topics: Anesthetics, Local; Animals; Biocompatible Materials; Bupivacaine; Cell Line; Coloring Agents; Drug Delivery Systems; Hyaluronic Acid; Hypromellose Derivatives; Inflammation; Male; Methylcellulose; Molecular Weight; Nerve Block; Rats; Rats, Sprague-Dawley; Rheology; Sciatic Nerve; Solutions; Tetrazolium Salts; Thiazoles; Viscosity | 2010 |
Alpha-lipoic acid prevents bupivacaine-induced neuron injury in vitro through a PI3K/Akt-dependent mechanism.
Topics: Anesthetics, Local; Animals; Animals, Newborn; Annexin A5; Apoptosis; Bupivacaine; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hippocampus; L-Lactate Dehydrogenase; Mice; Mice, Inbred C57BL; Neuroblastoma; Neurons; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Thioctic Acid; Time Factors; Vitamin B Complex | 2010 |